Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2016

01-01-2016 | Original Paper

Alcohol Use and HIV Testing in a National Sample of Women

Authors: Angela W. Walter, Lena Lundgren, Amarachi Umez-Eronini, Grant A. Ritter

Published in: AIDS and Behavior | Special Issue 1/2016

Login to get access

Abstract

The HIV/AIDS epidemic continues to disproportionately affect racial and ethnic minority groups and women in the United States. Prevention research suggests that reduced alcohol use and increased HIV testing are associated with lower incidence of HIV transmission among high-risk populations. Multivariable logistic regression analyses of the 2009 National Health Interview Survey data were performed for a national sample of 15,470 adult women to examine the relationship between alcohol use and likelihood of HIV testing. There is a significant association between level of alcohol use and HIV testing. Women who identified as heavy drinkers and moderate drinkers were significantly less likely to report ever testing for HIV. Findings add to the limited literature on the association between alcohol use and HIV testing behaviors among women. Given the incidence of HIV among women, this study highlights the importance of HIV testing, especially for alcohol-using women.
Literature
1.
The White House Office of National AIDS Policy. The National HIV/AIDS Strategy for the United States July 2010.
2.
Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007–2010 December 2012.
3.
4.
Nicolosi A, Correa Leite ML, Musicco M, Arici C, Gavazzeni G, Lazzarin A, Italian Study Group on HIV Heterosexual Transmission. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Epidemiology. 1994;5(6):570–5.PubMedCrossRef
5.
Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA. 1991;266(12):1664–7.PubMedCrossRef
6.
Campbell CA. Women, families and HIV/AIDS: a sociological perspective on the epidemic in America 1999. New York: Cambridge University Press; 1999.CrossRef
7.
Kates J, et al. A report on women and HIV/AIDS in the U.S.: Kaiser Family Foundation;2013.
8.
Cohen LR, Tross S, Pavlicova M, Hu MC, Campbell AN, Nunes EV. Substance use, childhood sexual abuse, and sexual risk behavior among women in methadone treatment. Am J Drug Alcohol Abuse. 2009;35(5):305–10.PubMedPubMedCentralCrossRef
9.
Richter L, Komarek A, Desmond C, et al. Reported physical and sexual abuse in childhood and adult HIV risk behaviour in three African countries: findings from Project Accept (HPTN-043). AIDS Behav. 2014;18(2):381–9.PubMedPubMedCentralCrossRef
10.
Hall BJ, Hall JC, Cockerell CJ. At 30 years: HIV/AIDS and other STDs among persons who use psychoactive drugs, in HIV/AIDS in the post-HAART era: manifestations, treatment, and epidemiology. In: Des Jarlais DC, Semaan S, Arancia G, editors. HIV/AIDS in the post-HAART era: manifestations, treatment, and epidemiology. Shelton: People’s Medical Publishing House; 2011. p. 753–78.
11.
Lansky A, Brooks JT, DiNenno E, Heffelfinger J, Hall HI, Mermin J. Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S64–8.PubMedCrossRef
12.
13.
14.
15.
16.
Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–66.PubMedCrossRef
17.
Avins AL, Woods WJ, Lindan CP, Hudes ES, Clark W, Hulley SB. HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA. 1994;271(7):515–8.PubMedCrossRef
18.
Boscarino JA, Avins AL, Woods WJ, Lindan CP, Hudes ES, Clark W. Alcohol-related risk factors associated with HIV infection among patients entering alcoholism treatment: implications for prevention. J Stud Alcohol. 1995;56(6):642–53.PubMedCrossRef
19.
Bailey SL, Pollock NK, Martin CS, Lynch KG. Risky sexual behaviors among adolescents with alcohol use disorders. J Adolesc Health. 1999;25(3):179–81.PubMedCrossRef
20.
Gerbi GB, Habtemariam T, Tameru B, Nganwa D, Robnett V. The correlation between alcohol consumption and risky sexual behaviors among people living with HIV/AIDS. J Subst Use. 2009;14(2):90–100.PubMedPubMedCentralCrossRef
21.
Raj A, Reed E, Santana MC, et al. The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. Drug Alcohol Depend. 2009;101(1–2):101–6.PubMedCrossRef
22.
Stein MD, Hanna L, Natarajan R, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat. 2000;18(4):359–63.PubMedCrossRef
23.
Stein MD, Anderson B, Charuvastra A, Friedmann PD. Alcohol use and sexual risk taking among hazardously drinking drug injectors who attend needle exchange. Alcohol Clin Exp Res. 2001;25(10):1487–93.PubMedCrossRef
24.
Malow RM, Devieux JG, Jennings T, Lucenko BA, Kalichman SC. Substance-abusing adolescents at varying levels of HIV risk: psychosocial characteristics, drug use, and sexual behavior. J Subst Abuse. 2001;13(1–2):103–17.PubMedCrossRef
25.
Cooper ML. Alcohol use and risky sexual behavior among college students and youth: evaluating the evidence. J Stud Alcohol Suppl. 2002;14:101–17.PubMedCrossRef
26.
Fromme K, D’Amico EJ, Katz EC. Intoxicated sexual risk taking: an expectancy or cognitive impairment explanation? J Stud Alcohol. 1999;60(1):54–63.PubMedCrossRef
27.
MacDonald TK, MacDonald G, Zanna MP, Fong GT. Alcohol, sexual arousal, and intentions to use condoms in young men: applying alcohol myopia theory to risky sexual behavior. Health Psychol. 2000;19(3):290–8.PubMedCrossRef
28.
U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies. National Survey on Drug Use and Health National Findings: Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in the Past Month among Persons Aged 21 or Older, by Demographic Characteristics, Percentages, 2006 and 2007. Rockville, MD: Substance Abuse and Mental Health Services Administration;2008.
29.
U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies. National Survey on Drug Use and Health National Findings: Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in the Past Month among Persons Aged 12 or Older, by Demographic Characteristics, Percentages, 2008 and 2009. Rockville, MD: Substance Abuse and Mental Health Services Administration;2009.
30.
Davey-Rothwell MA, Tobin K, Yang C, Sun CJ, Latkin CA. Results of a randomized controlled trial of a peer mentor HIV/STI prevention intervention for women over an 18 month follow-up. AIDS Behav. 2011;15(8):1654–63.PubMedPubMedCentralCrossRef
31.
Koblin BA, Bonner S, Hoover DR, et al. A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY study. J Acquir Immune Defic Syndr. 2010;53(3):378–87.PubMedPubMedCentralCrossRef
32.
Scott-Sheldon LA, Huedo-Medina TB, Warren MR, Johnson BT, Carey MP. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010. J Acquir Immune Defic Syndr. 2011;58(5):489–98.PubMedCrossRef
33.
Yang X, Xia G, Li X, Latkin C, Celentano D. The efficacy of a peer-assisted multi-component behavioral intervention among female entertainment workers in China: an initial assessment. AIDS Care. 2011;23(11):1509–18.PubMedPubMedCentralCrossRef
34.
Stein MD, Crystal S, Cunningham WE, et al. Delays in seeking HIV care due to competing caregiver responsibilities. Am J Public Health. 2000;90(7):1138–40.PubMedPubMedCentralCrossRef
35.
Turner BJ, Cunningham WE, Duan N, et al. Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med. 2000;160(17):2614–22.PubMedCrossRef
36.
Brewer TH, Zhao W, Metsch LR, Coltes A, Zenilman J. High-risk behaviors in women who use crack: knowledge of HIV serostatus and risk behavior. Ann Epidemiol. 2007;17(7):533–9.PubMedCrossRef
37.
Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.PubMedCrossRef
38.
Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008;47(4):577–84.PubMedCrossRef
39.
Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89(9):1397–405.PubMedPubMedCentralCrossRef
40.
Gelberg L, Andersen RM, Leake BD. The Behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.PubMedPubMedCentral
41.
Aday L, Awe R. Health Services Utilization Model. In: Gochman D, editor. Handbook of health behavior research: determinants of health behavior: personal and social, vol. 1. New York: Plenum Publishing Co.; 1997.
42.
Andersen R. A behavioral model of families’ use of health services. Chicago: University of Chicago Press, Center for Health Administration Studies Research Series; 1968.
43.
Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.PubMedCrossRef
44.
Benavides Torres RA, Wall KM, Nunez Rocha GM, Onofre Rodriguez DJ, Hopson L. Factors associated with lifetime HIV testing in Texas by race/ethnicity. Open AIDS J. 2012;6:232–8.PubMedPubMedCentralCrossRef
45.
CDC. Late versus early testing of HIV–16 Sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52(25):581–6.
46.
Ebrahim SH, Anderson JE, Weidle P, Purcell DW. Race/ethnic disparities in HIV testing and knowledge about treatment for HIV/AIDS: United States, 2001. AIDS Patient Care STDS. 2004;18(1):27–33.PubMedCrossRef
47.
Johnson DF, Sorvillo FJ, Wohl AR, et al. Frequent failed early HIV detection in a high prevalence area: implications for prevention. AIDS Patient Care STDS. 2003;17(6):277–82.PubMedCrossRef
48.
DeVoe JE, Fryer GE, Phillips R, Green L. Receipt of preventive care among adults: insurance status and usual source of care. Am J Public Health. 2003;93(5):786–91.PubMedPubMedCentralCrossRef
49.
Fox JB, Shaw FE. Relationship of income and health care coverage to receipt of recommended clinical preventive services by adults—United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2014;63(31):666–70.PubMed
50.
McMorrow S, Kenney GM, Goin D. Determinants of receipt of recommended preventive services: implications for the Affordable Care Act. Am J Public Health. 2014;104(12):2392–9.PubMedCrossRef
51.
Ohl ME, Perencevich E. Frequency of human immunodeficiency virus (HIV) testing in urban vs. rural areas of the United States: results from a nationally-representative sample. BMC Public Health. 2011;11:681.PubMedPubMedCentralCrossRef
52.
53.
SAS Institute Inc. Cary: SAS Institute Inc.;2014.
54.
Gunzerath L, Faden V, Zakhari S, Warren K. National Institute on Alcohol Abuse and Alcoholism report on moderate drinking. Alcohol Clin Exp Res. 2004;28(6):829–47.PubMedCrossRef
55.
56.
Bryant KJ. Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS. Subst Use Misuse. 2006;41(10–12):1465–507.PubMedCrossRef
57.
Weinhardt LS, Carey MP. Does alcohol lead to sexual risk behavior? Findings from event-level research. Annu Rev Sex Res. 2000;11:125–57.PubMedPubMedCentral
58.
Chander G, Josephs J, Fleishman JA, et al. Alcohol use among HIV-infected persons in care: results of a multi-site survey. HIV Med. 2008;9(4):196–202.PubMedPubMedCentralCrossRef
59.
Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007;46(2):194–9.PubMedPubMedCentralCrossRef
60.
Theall KP, Clark RA, Powell A, Smith H, Kissinger P. Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS Behav. 2007;11(2):205–15.PubMedCrossRef
61.
Cook RT. Alcohol abuse, alcoholism, and damage to the immune system—a review. Alcohol Clin Exp Res. 1998;22(9):1927–42.PubMed
62.
Meyerhoff DJ. Effects of alcohol and HIV infection on the central nervous system. Alcohol Res Health. 2001;25(4):288–98.PubMed
63.
Strauss SM, Tiburcio NJ, Munoz-Plaza C, et al. HIV care providers’ implementation of routine alcohol reduction support for their patients. AIDS Patient Care STDS. 2009;23(3):211–8.PubMedPubMedCentralCrossRef
64.
65.
Fleming MF. Strategies to increase alcohol screening in health care settings. Alcohol Health Res World. 1997;21(4):340–7.PubMed
66.
Terrell F, Zatzick DF, Jurkovich GJ, et al. Nationwide survey of alcohol screening and brief intervention practices at US Level I trauma centers. J Am Coll Surg. 2008;207(5):630–8.PubMedPubMedCentralCrossRef
67.
Zarkin GA, Bray JW, Davis KL, Babor TF, Higgins-Biddle JC. The costs of screening and brief intervention for risky alcohol use. J Stud Alcohol. 2003;64(6):849–57.PubMedCrossRef
68.
Moyer VA. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;159(3):210–8.PubMed
69.
Moyer VA. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013;159(1):51–60.PubMed
Metadata
Title
Alcohol Use and HIV Testing in a National Sample of Women
Authors
Angela W. Walter
Lena Lundgren
Amarachi Umez-Eronini
Grant A. Ritter
Publication date
01-01-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 1/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1144-5

Other articles of this Special Issue 1/2016

AIDS and Behavior 1/2016 Go to the issue

Original Paper

Developmental Cognitive Neuroscience of Adolescent Sexual Risk and Alcohol Use

Original Paper

Toward Development of Enhanced Preventive Interventions for HIV Sexual Risk among Alcohol-Using Populations: Confronting the ‘Mere Pause from Thinking’

Original Paper

Reducing HIV Risks in the Places Where People Drink: Prevention Interventions in Alcohol Venues

Original Paper

Optimization of Multicomponent Behavioral and Biobehavioral Interventions for the Prevention and Treatment of HIV/AIDS

Original Paper

Alcohol Use Problems and Sexual Risk Among Young Adult African American Mothers

Original Paper

Alcohol Use Predicts Number of Sexual Partners for Female but not Male STI Clinic Patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits